aspartic acid has been researched along with Anemia, Congenital Nonspherocytic Hemolytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, R; Bellingham, AJ; Lalloz, MR; Layton, DM | 1 |
| Bolch, KC; Gravely, M; Huisman, TH; Jonxis, JH; Kuis-Reerink, JD; Niazi, GA; Wilson, JB | 1 |
2 other study(ies) available for aspartic acid and Anemia, Congenital Nonspherocytic Hemolytic
| Article | Year |
|---|---|
Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency.
Topics: Anemia, Hemolytic, Congenital Nonspherocytic; Aspartic Acid; Deoxyribonucleases, Type II Site-Specific; Europe; Female; Founder Effect; Glutamic Acid; Haplotypes; Humans; Male; Mutation; Pedigree; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Restriction Mapping; Triose-Phosphate Isomerase | 1997 |
Hb-Volga or alpha 2 beta 2 27(B9)Ala replaced by Asp. An unstable hemoglobin variant in three generations of a Dutch family.
Topics: Alanine; Amino Acid Sequence; Anemia, Hemolytic, Congenital Nonspherocytic; Aspartic Acid; Drug Stability; Female; Genetic Variation; Hemoglobins, Abnormal; Humans; Male; Pedigree; Protein Conformation | 1976 |